Vimarsana
Biggest News Aggregation in the World

Page 7 - Penn Memory News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Penn Memory. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Penn Memory Today - Breaking & Trending Today

The toll dementia takes on families and finances - Vimarsana News

The toll dementia takes on families and finances

Cognitive decline makes people more vulnerable to financial mismanagement and exploitation. A growing body of research is clear — financial problems are not just a result of dementia, but can be a predictor.

Source: wesa.fm
Targeted News Service - Vimarsana News

Targeted News Service

Targeted News Service provides Washington Bureau coverage, federal contract and contracting information for awards and for subcontracting opportunities, a congressional vote chart, federal and congressional press releases.

You're invited: Michigan Alzheimer's Disease Center event at Literati Bookstore – Michigan Medicine Headlines - Vimarsana News

You're invited: Michigan Alzheimer's Disease Center event at Literati Bookstore – Michigan Medicine Headlines

Please join the Michigan Alzheimer’s Disease Center on Monday, Nov. 28 from 6 – 7:30 p.m. for a special event.  Jason Karlawish, M.D., professor of medicine at the Perelman School of Medicine at the University of Pennsylvania and director of the Penn Memory Center’s Outreach, Recruitment and Educ

Sizing Up the Decisions of Older Adults - Vimarsana News

Sizing Up the Decisions of Older Adults

A new training tool helps to assess whether some seniors can make informed choices about their own care and well-being.

Medicare and Medicaid limit coverage of new Alzheimer's drug - Vimarsana News

Medicare and Medicaid limit coverage of new Alzheimer's drug

Earlier this month, the Centers for Medicare and Medicaid Services announced it would cover the costs of a new Alzheimer’s drug. However, only if patients participate in clinical trials.The drug Aduhelm was approved last summer by the FDA. It was the first new Alzheimer’s drug approved since 2003.

Source: kjzz.org